In this episode, TRC Healthcare editor, Rachel Cole, PharmD, unpacks the updated recommendations for H. pylori management, spotlighting why bismuth quadruple therapy is now front and center and how to navigate antibiotic resistance and patient-specific factors. You’ll come away with actionable pearls on regimen selection, adherence strategies, and which drug interactions to watch for.

This is an excerpt from our February 2025 Pharmacy Essential Updates continuing education webinar series.

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:

• Article: Stay Current on H. pylori Treatment Guidance
• Chart: Helicobacter pylori: From Diagnosis to Eradication
• Graphic: Helicobacter pylori Treatment Summary

Don’t miss out! Subscribe today to stay ahead with trusted insights and tools.

Use code cc1025 at checkout for 10% off a new subscription.

🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter.

****

📝 We’d love to hear from you!

Take our quick listener survey—it only takes a minute and helps us make the show even better. Plus, you’ll be entered to win a $25 gift card!

📣 Share your thoughts here: https://forms.office.com/r/H2nLqzBwQc📣

****

Send us a text

If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.

Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, digs into Suzetrigine—brand name Journavx—the first non-opioid analgesic approved in over two decades.

You’ll hear how it works, how it compares to hydrocodone/acetaminophen, and why it might be a game-changer for patients at risk of opioid misuse. We’ll also unpack limitations in the clinical trials, cost concerns, dosing nuances, and key drug interactions to watch for. Plus, we’ll share tips for counseling patients and navigating formulary decisions, especially if your site participates in the manufacturer’s pilot program.

Don’t miss our quick skim graphic and comparison resource to help you make informed decisions.

This is an excerpt from our April 2025 Pharmacy Essential Updates continuing education webinar series.

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:

• Article: Explain How Suzetrigine Stacks Up for Acute Pain
• Graphic: New Drug: Suzetrigine (Journavx)
• Resource: Analgesics for Acute Pain in Adults

Don’t miss out! Subscribe today to stay ahead with trusted insights and tools.

Use code cc1025 at checkout for 10% off a new subscription.

🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter.

****

📝 We’d love to hear from you!

Take our quick listener survey—it only takes a minute and helps us make the show even better. Plus, you’ll be entered to win a $25 gift card!

📣 Share your thoughts here: https://forms.office.com/r/H2nLqzBwQc📣

****

Send us a text

If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.

Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, discusses recently approved drug formulations that bring fresh options—and new challenges—to the pharmacy counter.

From Arbli, the first ready-to-use losartan suspension, to Emrosi, a low-dose minocycline for rosacea, and Opipza, an oral film version of aripiprazole, we’ll walk through what makes each product unique and what pharmacy teams should watch for. We also cover HemiClor, a 12.5 mg chlorthalidone tablet that may help patients avoid splitting unscored tabs, Neffy, a needle-free epinephrine nasal spray now available in a pediatric strength, and wrap up with biosimilar updates on Merilog and Omlyclo.

This is an excerpt from our June 2025 Pharmacy Essential Updates continuing education webinar series.

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:

• Article: Watch for New Twists to Older Medications
• Chart: Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors
• Chart: Treatments for Rosacea
• Chart: Comparison of Commonly Used Diuretics
• Chart: Comparison of Atypical Antipsychotics
• Chart: Emergency Epinephrine Devices
• Chart: Facts About Biosimilars

Use code cc1025 at checkout for 10% off a new subscription.

Send us a text

****

Join the National Community Pharmacists Associations’ Annual Convention (NCPA) in New Orleans October 18-21st: https://bit.ly/ncpameeting25

****

If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.

Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

In this episode, TRC Healthcare editor, Sara Klockars, PharmD, BCPS unpacks the newly approved use of tirzepatide (Zepbound) for obstructive sleep apnea (OSA)—a first-in-class pharmacologic option for a condition long managed with devices and lifestyle changes.

You’ll hear a concise review of sleep apnea pathophysiology, how tirzepatide works to reduce airway obstruction, and what the latest clinical trials reveal about its efficacy and safety. Plus, you’ll get practical pharmacy-focused insights on side effect management, payer considerations, and how to avoid duplicate GLP-1 therapy.

This is an excerpt from our April 2025 Pharmacy Essential Updates continuing education webinar series.

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:

• Article: Watch for Tirzepatide for Sleep Apnea
• Chart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart

Don’t miss out! Subscribe today to stay ahead with trusted insights and tools.

Use code podcast1025 at checkout for 10% off a new subscription.

🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter.

****

GLP-1 Essentials from TRC Healthcare – Now Available

Master the essentials of GLP-1 therapy with this focused GLP-1 agonists CE bundle. Get 4 hours of CE plus clinical tools to help you prescribe, titrate, switch therapies, and support patients confidently.

Courses include:

• GLP-1 Agonists: Understanding the Essentials (1.5 hours)
• GLP-1 Agonists: Supporting Success with Nutrition and Lifestyle Considerations (1 hour)
• GLP-1 Agonists: Optimizing Therapy Across Clinical Scenarios (1.5 hours)
• GLP-1 Agonists: Pipeline and Emerging Therapies (no CE credit; regular updates planned)

Now included with Pharmacist’s Letter Platinum and Diamond subscriptions, or available as a standalone CE experience.

****

Send us a text

****

Join the National Community Pharmacists Associations’ Annual Convention (NCPA) in New Orleans October 18-21st: https://bit.ly/ncpameeting25

****

If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.

Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, guides listeners through the evolving landscape of biosimilars, highlighting their increasing presence in pharmacy practice and their critical distinctions from traditional generics. She explains the science behind biologics, the FDA’s rigorous approval process for biosimilars, and the nuances of interchangeability. With examples of biosimilars for Stelara, Humira, and Prolia, Vickie illustrates how pharmacists can confidently counsel patients, verify product details, and stay compliant with state laws.

Whether you're stocking shelves or answering patient questions, this episode equips you with the knowledge to handle biosimilars with confidence, precision, and care.

This is an excerpt from our January 2025 Pharmacy Essential Updates continuing education webinar series.

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:

• Article: Brush Up on Biosimilars
• FAQ: Facts About Biosimilars

Don’t miss out! Subscribe today to stay ahead with trusted insights and tools.

Use code podcast1025 at checkout for 10% off a new subscription.

🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter.

Send us a text

****

Join the National Community Pharmacists Associations’ Annual Convention (NCPA) in New Orleans October 18-21st: https://bit.ly/ncpameeting25

****

If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.

Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

In this episode, TRC Healthcare editor, Rachel Cole, PharmD, delves into the debate about whether newer medications for Type 2 diabetes, including SGLT-2 inhibitors or GLP-1 agonists, should be used first-line instead of metformin. She examines the benefitsand drawbacks of these newer medications, including their cardiovascular and kidney benefits, side effects, and costs.

This is an excerpt from our March 2025 Pharmacy Essential Updates continuing education webinar series.

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:

• Article: Stay Current on Med Recommendations for Diabetes
• Algorithm: Stepwise Treatment of Type 2 Diabetes
• Chart: Diabetes Medications: Cardiovascular and Kidney Impact
• Resource Hub: Diabetes

Don’t miss out! Subscribe today to stay ahead with trusted insights and tools.

Use code podcast1025 at checkout for 10% off a new subscription.

🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter.

Send us a text

****

Join the National Community Pharmacists Associations’ Annual Convention (NCPA) in New Orleans October 18-21st: https://bit.ly/ncpameeting25

****

If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.

Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

In this episode, TRC Healthcare editor, Don Weinberger, PharmD, PMSP, explores how to avoid medication mishaps with pet prescriptions. Learn about common pitfalls, species-specific risks, and best practices for pharmacists and technicians.

This is an excerpt from our December 2024 Pharmacy Essential Updates continuing education webinar series.

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:

• Article: Don’t Chase Your Tail With Pet Rxs
• FAQ: Med Considerations for Cats and Dogs

Don’t miss out! Subscribe today to stay ahead with trusted insights and tools.

Use code podcast1025 at checkout for 10% off a new subscription.

🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter.

Send us a text

If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.

Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, discusses Doxycycline Post-Exposure Prophylaxis for STIs.

This is an excerpt from our August 2024 Pharmacy Essential Updates continuing education webinar series.

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:

• Chart: Drugs with Different Salt Forms
• Checklist: HIV Postexposure Prophylaxis (PEP) Checklist
• Chart: Sexually Transmitted Infections

Don’t miss out! Subscribe today to stay ahead with trusted insights and tools.

Our listeners can get 10% off a new subscription with code podcast1025 at checkout.

If you're a student, good news—students can access a free version of Pharmacist’s Letter.

Send us a text

If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.

Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.